Article Text

Download PDFPDF
Diagnosing autism spectrum disorder (ASD) among adults
  1. Toshi A Furukawa
  1. Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan; furukawa@kuhp.kyoto-u.ac.jp

Statistics from Altmetric.com

Clinical case

Patient: 18-year-old man

Present illness: The patient was brought to your department of psychiatry by his worried mother. While the patient sat still on the chair, directing an unmoving suspicious gaze towards you, his mother explained in a hurried, high-pitched voice, as follows: “Adam (the patient's name) has always been an odd boy. We've recently heard a lot about Asperger's syndrome and autism in the newspapers and on TV. I'm convinced that he suffers from them and told our family doctor, but he wasn't sure and sent us to you. Adam was very difficult to raise from the very beginning. Maybe he was a bit late in starting to walk or to talk but we did not think it was unusual, in comparison with his sister. When he went to the kindergarten and to primary school, he never had any friends. He always played alone and was interested in cartoon monsters. All he did was to collect monster cards. Things just had to be the way he wanted and he had tantrums when something unexpected happened. Oh yes, he also killed a lot of frogs with firecrackers—isn't this weird? Isn't he a weird boy? He was never good at school, probably always the worst or the second worst in class, and kids started bullying him. He started skipping class, but with understanding teachers he has so far managed to finish primary school and junior high school, and he is now a senior in high school. But he probably will now have to drop out: he has not gone to school for two months now. I am so worried. What will he do for his life?”

Present status: All this while Adam sat still, without changing his facial expression except for occasional grimaces. When asked what he himself thought was his problems, he …

View Full Text

Footnotes

  • Competing interests TAF has received lecture fees from Eli Lilly, Janssen, Meiji, MSD, Otsuka, Pfizer and Tanabe-Mitsubishi, and consultancy fees from Sekisui Chemicals and Takeda Science Foundation. He has received royalties from Igaku-Shoin and Nihon Bunka Kagaku-sha publishers. He has received grants or research support from the Japanese Ministry of Education, Science and Technology, the Japanese Ministry of Health, Labour and Welfare, the Japan Society for the Promotion of Science, the Japan Foundation for Neuroscience and Mental Health, Mochida and Tanabe-Mitsubishi. He is diplomate of the Academy of Cognitive Therapy.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.